Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no. SEBIIHO/CFO/CMD1/CIRIP/2021/662 dated November 22, 2021, Panacea Biotec has informed that it enclosed disclosure of related party transactions for half year ended September 30, 2022.
The above information is a part of company’s filings submitted to BSE.